Phase 3 Boosting Study for the SARS-CoV-2 rS Variant Vaccines

Clinical trial NCT05372588 · COMPLETED

Trial details

NCT number: NCT05372588
Sponsor: Novavax
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

COVID-19 SARS CoV 2 Infection

Start date: 2022-05-25
Primary completion: 2022-07-17
Enrollment: 1340

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.